Primary Care
Speaker Two Article Five: Nullam euismod, quam ut viverra auctor
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Speaker Two Article One: Nullam euismod, quam ut viverra auctor
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Adams Article Two: Donec sed purus id dui hendrerit dictum eu vulputate felis
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Adams Article Three: Nunc augue lorem
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Adams Article One: Duis eu sagittis metus
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Adams Article Four: Vivamus sed sem facilisis
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Adams Article Five: Donec semper pharetra nisl vitae molestie
Cras feugiat lectus orci, ut sagittis ligula pulvinar luctus. Mauris non enim et lorem molestie commodo in sit amet velit. Curabitur consectetur dictum sem.
Data bridge 'built out of binder-twine and hope' integrates primary care and public health
In Alberta, Canada, stakeholders built a data bridge between independent primary care providers and public health officials to share information on SARS-CoV-2 test results and ultimately improve community-based responses to the pandemic.
General CVD risk prediction tools appear to be useful for cancer survivors
CVD risk prediction tools developed for a primary care population in New Zealand were similarly useful risk predictors for adult cancer survivors, researchers reported.
Withdrawing inhaled corticosteroids does not appear to expedite FEV1 declines in COPD
Across cohorts of patients with COPD, withdrawing inhaled corticosteroids from triple therapy resulted in similar FEV1 declines as remaining on triple therapy, according to a study published in Annals of the American Thoracic Society.